「tam」の検索結果

Tamagui universal UI - styled(), tokens, themes, optimizing compiler, responsive media queries, animations, Sheet/Dialog components

日本語の概要は準備中です。原文の説明を表示しています。

Analyzes bootkit and rootkit samples by identifying boot-process tampering (MBR/VBR/ UEFI), kernel-mode components, and stealth hooking techniques from static indicators. Activates for requests to analyze a bootkit or rootkit, examine MBR/UEFI tampering, or identify kernel-mode stealth components.

日本語の概要は準備中です。原文の説明を表示しています。

Use when a task needs the judgment of an airfield operations specialist — running a Part 139 self-inspection of the movement area, assigning a Runway Condition Code (RwyCC) after snow/ice contamination, deciding whether a discovered hazard needs an immediate NOTAM, triggering a Wildlife Hazard Assessment after a strike or sighting, or judging a FOD find as immediate-closure versus scheduled removal.

日本語の概要は準備中です。原文の説明を表示しています。

Citation format and verification protocol for legal documents that draw on Bates-stamped source records. Defines the bracket citation format, multi-source citation rules, quotation handling, the verification pass that runs before output, and the [UNVERIFIED] flag protocol. Use this skill any time another skill produces a legal work product that cites Bates-stamped pages, including medical chronologies, deposition summaries, demand letters, case briefs, and discovery responses. Also use any time the user asks how to format a citation or verify that a claim is supported by the source.

日本語の概要は準備中です。原文の説明を表示しています。

Call germline SNPs and indels with GATK HaplotypeCaller and the GVCF joint-genotyping workflow. Covers the local-reassembly + PairHMM mechanism (why HC beats pileup callers on indels), the -ERC GVCF reference-confidence model and <NON_REF> allele, BQSR-vs-DRAGSTR and --dragen-mode error modeling, allele-specific (AS_) annotations, and edge cases (ploidy, Mutect2 mitochondria mode, sex chromosomes/PAR, contamination gating). Use when deciding whether to use HaplotypeCaller vs a pileup or DRAGEN caller, whether BQSR still earns its place, whether to call per-sample GVCFs for a cohort, or how to handle non-diploid, mitochondrial, sex-chromosome, or contaminated samples. Not for post-calling filtering depth (see variant-calling/filtering-best-practices) or cohort joint-genotyping scaling (see variant-calling/joint-calling).

日本語の概要は準備中です。原文の説明を表示しています。

Assesses the quality and completeness of a genome annotation with BUSCO (conserved single-copy ortholog recovery), OMArk (proteome completeness, consistency, and contamination), CheckM2 (prokaryotic completeness/contamination), and a gene-set sanity panel (gene count, mono-exonic fraction, protein-length distribution, mRNA:gene ratio, coding density). Covers the assembly-BUSCO-vs-proteome-BUSCO diagnostic, what BUSCO-Duplicated really means, why gene count is a vanity metric, and the QC of transferred annotations. Use when judging whether an annotation is good enough to publish or submit, diagnosing a suspect annotation, or comparing annotation completeness across pipelines.

日本語の概要は準備中です。原文の説明を表示しています。

Processes eDNA metabarcoding from raw paired-end reads to species tables, navigating ASV (DADA2, UNOISE3) vs OTU (swarm v2) decision (Callahan 2017 vs Schloss multi-copy-16S critique), marker/primer choice (Leray COI, MiFish 12S, 515F/806R 16S, ITS2) with primer-specific bias, OBITools3 v3 command-name break (obi stats plural; .tar.gz taxonomy), tag-jumping with dual-indexing (Schnell 2015; NovaSeq 10x MiSeq), decontam as screening-not-classifier (Davis 2018), read-counts-not-abundance critique (Lamb 2019), site-occupancy modeling (Ficetola 2015), Naive-Bayes calibration limits (Bokulich 2018), and eDNA decay (Strickler 2015). Use when going from raw eDNA FASTQ to species tables, picking marker + denoising pipeline, deciding whether read counts represent abundance, applying occupancy modeling, configuring OBITools3 v3, or interpreting decontam output. Not for clinical 16S microbiome (see microbiome/amplicon-processing).

日本語の概要は準備中です。原文の説明を表示しています。

Quantifies CRISPR editing outcomes with CRISPResso2 (Clement 2019 Nat Biotechnol) across Cas9-nuclease (indels, HDR), CBE and ABE base editors (target conversion + bystander), and prime editor (pegRNA-templated) modes. Covers single-amplicon (CRISPResso), multi-sample batch (CRISPRessoBatch), pooled-amplicon (CRISPRessoPooled), WGS off-target (CRISPRessoWGS), and sample-comparison (CRISPRessoCompare) workflows; quantification-window math that controls what is called edited; substitution-vs-indel diagnostic to distinguish BE from Cas9 contamination; MMEJ deletion pattern interpretation; allele-frequency tables; and failure modes from amplicon misalignment or contamination. Use when quantifying editing from amplicon sequencing, choosing CRISPResso mode by design, distinguishing intended edits from bystanders and indel byproducts, debugging low-alignment runs, or generating publication-grade editing reports.

日本語の概要は準備中です。原文の説明を表示しています。

This skill checks for contraindications or sources of inaccuracy that may affect continuous glucose monitoring (CGM) reliability in hospitalized adults. It is triggered when clinicians ask, “Are there factors that could make CGM unreliable?” or when assessing for skin infection, hypoperfusion, hypovolemia, vasoactive/pressor therapy, or medications such as acetaminophen >4 g/day, dopamine, vitamin C, or hydroxyurea.

日本語の概要は準備中です。原文の説明を表示しています。

Guidelines and strategies for constructing meaningful test suites, property-based tests, metamorphic relations, and fuzzing harnesses. Trigger when: - Designing verification bounds, writing tests, creating test invariants, or implementing validation gates. - Prompt contains: testing, test design, property-based testing, PBT, metamorphic testing, fuzzing, integration tests, E2E.

日本語の概要は準備中です。原文の説明を表示しています。

Detects defense evasion techniques used by adversaries in endpoint logs including log tampering, timestomping, process injection, and security tool disabling. Use when investigating suspicious endpoint behavior, building detection rules for evasion tactics, or conducting threat hunting for stealthy adversary activity. Activates for requests involving evasion detection, defense evasion analysis, log tampering detection, or MITRE ATT&CK TA0005.

日本語の概要は準備中です。原文の説明を表示しています。

Use when running the dev Grafana stack and/or the Playwright e2e suite against a *packaged* plugin zip (a release/RC artifact like `hydrolix-hydrolix-datasource-<ver>.zip`) rather than the working-tree `dist/`. Unpacks the package into a timestamped `dist_<timestamp>/dist` sandbox alongside copies of the compose artifacts, so the run is reproducible and the folder stays available to experiment with afterwards. Delegates stack bring-up to `stack-run` (frozen mode: read-only mount + `DEV=false` so the mage-watcher can't rebuild the packaged Go binary), verifies signature/version, runs the suite, and treats cleanup as optional — the sandbox is deleted only with the user's approval. Apply whenever the task is "test this plugin package / zip" or "run e2e against the built artifact".

日本語の概要は準備中です。原文の説明を表示しています。

Detects defense evasion techniques used by adversaries in endpoint logs including log tampering, timestomping, process injection, and security tool disabling. Use when investigating suspicious endpoint behavior, building detection rules for evasion tactics, or conducting threat hunting for stealthy adversary activity. Activates for requests involving evasion detection, defense evasion analysis, log tampering detection, or MITRE ATT&CK TA0005.

日本語の概要は準備中です。原文の説明を表示しています。

End-to-end eDNA metabarcoding from raw amplicons to community ecology. Covers QC, primer removal (mandatory before DADA2 filterAndTrim), denoising with OBITools3 v3 (obi stats plural; DMS-based) or DADA2 ASVs (Callahan 2017), decontam combined method as screening-not-classifier (Davis 2018), tag-jumping with NovaSeq 10x MiSeq caveat (Schnell 2015), Hill-number effective species counts with coverage-based rarefaction (Jost 2006; Chao & Jost 2012; doubling rule), beta-diversity decomposition with MANDATORY PERMANOVA + PERMDISP pair (Anderson & Walsh 2013), constrained ordination, and the read-counts-not-abundance critique (Lamb 2019). Use when processing eDNA samples for biodiversity assessment, deciding ASV vs OTU, configuring OBITools3 v3, interpreting decontam screening, or reporting community comparisons with the dispersion confound check.

日本語の概要は準備中です。原文の説明を表示しています。

Design what an employer will have a candidate do during an Otameshi Tenshoku trial: turn a business problem into a bounded paid assignment or an unpaid learning visit, with scope, completion criteria, candidate hours, company staff hours, duration, compensation and change conditions, and check the planned cost against the budget. Use when a hiring manager, recruiter or small-business owner wants to decide what work to offer, how much time it takes, what it costs, or how to adjust a plan when materials are late or the scope grows; do not use to write the public listing (trial-listing-draft), to reply to applicants (applicant-reply), to state market rates, legal, tax or service conditions from memory, or to post, contact or contract on the user's behalf.

日本語の概要は準備中です。原文の説明を表示しています。

Check, from the employer's side, what has been put in writing before a paid Otameshi Tenshoku assignment starts under gyomu-itaku: item by item whether the deliverable, delivery date, fee and how it is calculated, payment due date, who pays, out-of-scope work, revision limits, company support, rights, confidentiality and termination are stated in a contract, purchase order or email rather than in chat or by word of mouth, count the days from delivery to payment, and find pay tied to satisfaction or hiring, unpaid or unlimited revisions and one-sided termination. Use when a hiring manager, recruiter or small-business owner is about to offer terms to a candidate, has been asked by a candidate what is still unwritten, or needs the conditions written for a platform contract screen; do not use to judge whether the terms are lawful or the fee fair, to compute withholding or consumption tax, for employment contracts, or to sign, send or conclude the contract on the user's behalf.

日本語の概要は準備中です。原文の説明を表示しています。

Draft or review an employer's Otameshi Tenshoku listing so a candidate can decide whether to apply: check item by item that the work, deliverable, out-of-scope tasks, required experience, support, hours, schedule, location, compensation, contract form and payment timing are stated, find open-ended, unpaid-company-work, guarantee, personal-attribute and unverifiable wording, and confirm that the hours, weekly availability, period, rate and budget hold together. Use when a hiring manager, recruiter or small-business owner wants a listing written from a plan, wants an existing draft or published listing reviewed before or after posting, or wants to know why applications are not coming; do not use to design the work itself (trial-work-design), to reply to applicants (applicant-reply), to state market rates, legal, tax or service conditions from memory, or to post or update the listing on the user's behalf.

日本語の概要は準備中です。原文の説明を表示しています。

Debrief a finished Otameshi Tenshoku trial from the employer's side: set the observed facts against the completion criteria agreed before the start, keep expectations added afterwards, second-hand or off-the-job observations and the company's own late or missing support apart, settle the hours actually worked separately from any evaluation, and draft feedback to the candidate that states facts, support gaps and what happens next without promising a hire or continuation the company has not decided. Use when a hiring manager, recruiter or small-business owner wants to review a trial, decide what to tell the candidate, or work out the settlement after a shortfall; do not use to judge the candidate's aptitude or predict a hire, to cut pay or demand unpaid rework because of dissatisfaction, to compare candidates, or to send the feedback, pay, or update records on the user's behalf.

日本語の概要は準備中です。原文の説明を表示しています。

Prepare the internal case for hosting an Otameshi Tenshoku trial: total what it costs the company with candidate pay, staff hours and platform or incidental fees kept apart, compare it with the budget, state what remains if no hire follows, and lay out the risks, stop conditions, decision owners and deadlines. Use when a hiring manager needs approval or budget from a decision maker, a recruiter has to explain the plan to the team that will host, or a small-business owner wants to see the full cost including their own time before posting; do not use to design the work (trial-work-design), to write the listing (trial-listing-draft), to predict whether a hire will follow, to state platform fees, agency fees or market rates from memory, or to submit the request or post the listing on the user's behalf.

日本語の概要は準備中です。原文の説明を表示しています。

Reply to an applicant for an employer's Otameshi Tenshoku listing: match the application against the listed requirements item by item on what the applicant actually stated, list the questions still open, and draft an invitation, a request for clarification, a hold notice or a decline that sticks to the listed conditions, keeps other applicants and internal notes out, and presents any new work or dates as a proposal rather than an agreed term. Use when a hiring manager, recruiter or small-business owner has applications to answer, wants to know what to ask before inviting, or has to decline; do not use to judge an applicant's aptitude or predict hiring outcomes, to screen on personal attributes unrelated to the work, to design the work (trial-work-design) or the listing (trial-listing-draft), or to send the message or update applicant records on the user's behalf.

日本語の概要は準備中です。原文の説明を表示しています。

Assesses the quality and completeness of a genome annotation with BUSCO (conserved single-copy ortholog recovery), OMArk (proteome completeness, consistency, and contamination), CheckM2 (prokaryotic completeness/contamination), and a gene-set sanity panel (gene count, mono-exonic fraction, protein-length distribution, mRNA:gene ratio, coding density). Covers the assembly-BUSCO-vs-proteome-BUSCO diagnostic, what BUSCO-Duplicated really means, why gene count is a vanity metric, and the QC of transferred annotations. Use when judging whether an annotation is good enough to publish or submit, diagnosing a suspect annotation, or comparing annotation completeness across pipelines.

日本語の概要は準備中です。原文の説明を表示しています。

Processes eDNA metabarcoding from raw paired-end reads to species tables, navigating ASV (DADA2, UNOISE3) vs OTU (swarm v2) decision (Callahan 2017 vs Schloss multi-copy-16S critique), marker/primer choice (Leray COI, MiFish 12S, 515F/806R 16S, ITS2) with primer-specific bias, OBITools3 v3 command-name break (obi stats plural; .tar.gz taxonomy), tag-jumping with dual-indexing (Schnell 2015; NovaSeq 10x MiSeq), decontam as screening-not-classifier (Davis 2018), read-counts-not-abundance critique (Lamb 2019), site-occupancy modeling (Ficetola 2015), Naive-Bayes calibration limits (Bokulich 2018), and eDNA decay (Strickler 2015). Use when going from raw eDNA FASTQ to species tables, picking marker + denoising pipeline, deciding whether read counts represent abundance, applying occupancy modeling, configuring OBITools3 v3, or interpreting decontam output. Not for clinical 16S microbiome (see microbiome/amplicon-processing).

日本語の概要は準備中です。原文の説明を表示しています。

Quantifies CRISPR editing outcomes with CRISPResso2 (Clement 2019 Nat Biotechnol) across Cas9-nuclease (indels, HDR), CBE and ABE base editors (target conversion + bystander), and prime editor (pegRNA-templated) modes. Covers single-amplicon (CRISPResso), multi-sample batch (CRISPRessoBatch), pooled-amplicon (CRISPRessoPooled), WGS off-target (CRISPRessoWGS), and sample-comparison (CRISPRessoCompare) workflows; quantification-window math that controls what is called edited; substitution-vs-indel diagnostic to distinguish BE from Cas9 contamination; MMEJ deletion pattern interpretation; allele-frequency tables; and failure modes from amplicon misalignment or contamination. Use when quantifying editing from amplicon sequencing, choosing CRISPResso mode by design, distinguishing intended edits from bystanders and indel byproducts, debugging low-alignment runs, or generating publication-grade editing reports.

日本語の概要は準備中です。原文の説明を表示しています。

Assesses the quality and completeness of a genome annotation with BUSCO (conserved single-copy ortholog recovery), OMArk (proteome completeness, consistency, and contamination), CheckM2 (prokaryotic completeness/contamination), and a gene-set sanity panel (gene count, mono-exonic fraction, protein-length distribution, mRNA:gene ratio, coding density). Covers the assembly-BUSCO-vs-proteome-BUSCO diagnostic, what BUSCO-Duplicated really means, why gene count is a vanity metric, and the QC of transferred annotations. Use when judging whether an annotation is good enough to publish or submit, diagnosing a suspect annotation, or comparing annotation completeness across pipelines.

日本語の概要は準備中です。原文の説明を表示しています。